Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) EPS (diluted)
Intuitive Surgical, Inc.'s EPS (diluted) for fiscal 2025 was $7.87, up 22.6% from $6.42 in fiscal 2024. Over the twelve months to 30 June 2026 it was $8.73. Over the past ten years it has ranged from $1.73 (fiscal 2015) to $7.87 (fiscal 2025) — the current reading is the highest in ten years. EPS (diluted) has risen for 3 consecutive fiscal years. Intuitive Surgical, Inc. ranks 2nd of 49 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $7.87 | 22.59% |
| FY2024 | $6.42 | 27.63% |
| FY2023 | $5.03 | 37.81% |
| FY2022 | $3.65 | (21.67%) |
| FY2021 | $4.66 | 58.50% |
| FY2020 | $2.94 | (23.57%) |
| FY2019 | $3.85 | 21.60% |
| FY2018 | $3.16 | 67.37% |
| FY2017 | $1.89 | (9.18%) |
| FY2016 | $2.08 | 20.52% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $2.29 | 0.44% |
| Mar 2026 | $2.28 | 3.17% |
| Dec 2025 | $2.21 | 13.33% |
| Sep 2025 | $1.95 | 7.73% |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| RMD ResMed Inc. compare | $10.43 |
| ISRG Intuitive Surgical, Inc. | $8.73 |
| SOLV Solventum Corporation compare | $8.18 |
| WST West Pharmaceutical Services, Inc. compare | $7.81 |
| BDX Becton, Dickinson and Company compare | $3.32 |
| ALC Alcon compare | $1.31 |
| RGEN Repligen Corporation compare | $0.73 |
| BAX Baxter International Inc. compare | −$2.07 |
| MDLN Medline Inc. compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on ISRG
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement